Cargando…
New molecular classification of large cell neuroendocrine carcinoma and small cell lung carcinoma with potential therapeutic impacts
Large cell neuroendocrine carcinoma (LCNECs) and small cell lung carcinomas (SCLCs) are high-grade neuroendocrine carcinomas of the lung with very aggressive behavior and poor prognosis. Their histological classification as well as their therapeutic management has not changed much in recent years, b...
Autores principales: | Lantuejoul, Sylvie, Fernandez-Cuesta, Lynnette, Damiola, Francesca, Girard, Nicolas, McLeer, Anne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653155/ https://www.ncbi.nlm.nih.gov/pubmed/33209646 http://dx.doi.org/10.21037/tlcr-20-269 |
Ejemplares similares
-
Outsourcing predictive biomarker testing in non-small cell carcinoma: a personal view of pathologists
por: Brcic, Luka, et al.
Publicado: (2020) -
New insights into the interaction of the immune system with non-small cell lung carcinomas
por: Hofman, Paul
Publicado: (2020) -
How should molecular findings be integrated in the classification for lung cancer?
por: Hung, Yin P., et al.
Publicado: (2020) -
New developments in lung cancer diagnosis and pathological patient management strategies
por: Popper, Helmut
Publicado: (2020) -
Patient-derived cell line, xenograft and organoid models in lung cancer therapy
por: Huo, Ku-Geng, et al.
Publicado: (2020)